Prognostic value of baseline metabolic tumor volume measured on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy

PURPOSE: Ipilimumab induces durable remissions in about 15–20% of patients with metastatic melanoma. However, reliable predictors for response to ipilimumab are currently lacking. Whole-body metabolic tumor volume (wMTV) has been shown to be a strong prognostic factor in a variety of malignancies tr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur J Nucl Med Mol Imaging
Huvudupphovsmän: Ito, Kimiteru, Schöder, Heiko, Teng, Rebecca, Humm, John L., Ni, Ai, Wolchok, Jedd D., Weber, Wolfgang A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451667/
https://ncbi.nlm.nih.gov/pubmed/30488098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4211-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk